New York State Common Retirement Fund’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-53,211
| Closed | -$7.45M | – | 3199 |
|
|
2018
Q4 | $7.45M | Buy |
53,211
+21,161
| +66% | +$3.21M | 0.01% | 1013 |
|
|
2018
Q3 | $5.47M | Buy |
32,050
+600
| +2% | +$101K | 0.01% | 1231 |
|
|
2018
Q2 | $5.46M | Buy |
31,450
+6,750
| +27% | +$1.01M | 0.01% | 1236 |
|
|
2018
Q1 | $2.85M | Buy |
24,700
+400
| +2% | +$42.5K | ﹤0.01% | 1454 |
|
|
2017
Q4 | $2.05M | Sell |
24,300
-797
| -3% | -$66.4K | ﹤0.01% | 1629 |
|
|
2017
Q3 | $2.31M | Buy |
25,097
+700
| +3% | +$54.4K | ﹤0.01% | 1559 |
|
|
2017
Q2 | $1.96M | Buy |
24,397
+8,696
| +55% | +$482K | ﹤0.01% | 1685 |
|
|
2017
Q1 | $661K | Buy |
15,701
+1,001
| +7% | +$41.2K | ﹤0.01% | 2242 |
|
|
2016
Q4 | $472K | Sell |
14,700
-4,173
| -22% | -$107K | ﹤0.01% | 2396 |
|
|
2016
Q3 | $494K | Buy |
18,873
+4,400
| +30% | +$115K | ﹤0.01% | 2320 |
|
|
2016
Q2 | $335K | Buy |
14,473
+523
| +4% | +$13K | ﹤0.01% | 2470 |
|
|
2016
Q1 | $381K | Buy |
13,950
+3,200
| +30% | +$67K | ﹤0.01% | 2362 |
|
|
2015
Q4 | $306K | Hold |
10,750
| – | – | ﹤0.01% | 2550 |
|
|
2015
Q3 | $188K | Sell |
10,750
-766
| -7% | -$15K | ﹤0.01% | 2817 |
|
|
2015
Q2 | $208K | Buy |
11,516
+6,416
| +126% | +$87.7K | ﹤0.01% | 2902 |
|
|
2015
Q1 | $63K | Buy |
+5,100
| New | +$63.5K | ﹤0.01% | 2248 |
|
Other funds holding LOXO
New York State Common Retirement Fund's LOXO Position: Q1 2019 in Review
New York State Common Retirement Fund sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 53,211 shares — an estimated $7.45M sold.
New York State Common Retirement Fund first reported a position in LOXO in Q1 2015 and held it in 16 quarters. The position peaked at $7.45M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- New York State Common Retirement Fund reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- New York State Common Retirement Fund sold 53,211 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.45M.
- New York State Common Retirement Fund first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 16 quarters.
- New York State Common Retirement Fund's Loxo Oncology, Inc position peaked at $7.45M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on New York State Common Retirement Fund's 13F filing for Q1 2019, filed 8 May 2019.